Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 5/20 | 0.40 |
| ▸ | PARL | Q9H300 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL118685 | 0.90 | PARL (0.41) | MGLLPARLKMT2AATMCA12 | |
| SCHEMBL13423603 | 0.89 | MGLL (0.36) | MGLL | |
| SCHEMBL10889616 | 0.85 | GLA (0.39) | MGLLPARLKMT2AATMGLA | |
| SCHEMBL28377582 | 0.85 | MGLL (0.36) | MGLLPARL | |
| SCHEMBL1580294 | 0.84 | MGLL (0.38) | MGLLPARL | |
| SCHEMBL28964134 | 0.84 | MGLL (0.36) | MGLLPARLKMT2AATMCA12 | |
| SCHEMBL17447 | 0.83 | MGLL (0.37) | MGLLPARLGLACA12CA1 | |
| SCHEMBL11596423 | 0.83 | ALDH1A1 (0.37) | MGLLKMT2AATM | |
| Ethylene Glycol SCHEMBL29130624 | 0.82 | PARL (0.36) | MGLLPARLKMT2AATMALOX12 | |
| SCHEMBL73278 | 0.82 | KMT2A (0.47) | MGLLKMT2AATMGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110204576-B | Preparation method of lithium difluorobis (oxalato) phosphate solution | 东莞东阳光科研发有限公司 | 2021-09-10 | — | — | CN | claimed |
| US-20200388880-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| CN-109072482-A | MULTIVALENT GLYCAN MICROARRAY PLATFORM | Z生物科技有限公司 | 2018-12-21 | — | — | CN | claimed |
| US-20100022415-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | AVICOR KET. (HU) | 2010-01-28 | — | — | US | claimed |
| CN-101553731-A | Active carrier, its production and its use | AVICOR KFT (HU) | 2009-10-07 | — | — | CN | claimed |
| EP-2080026-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | Avicor Kft. (HU) | 2009-07-22 | — | — | EP | claimed |
| WO-2008023208-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | AVICOR KFT. (HU) | 2008-02-28 | — | — | WO | claimed |
| JP-2006517995-A | — | — | 2006-08-03 | — | — | JP | claimed |
| EP-1597299-A2 | CARBONATE ESTERS OF POLYETHYLENE GLYCOL ACTIVATED BY MEANS OF OXALATE ESTERS | Pharmacia Corporation (US) | 2005-11-23 | — | — | EP | claimed |
| EP-1131281-B1 | DERIVATISATION OF SUPPORT SURFACES | DEUTSCHES KREBSFORSCH (DE) | 2005-07-27 | — | — | EP | claimed |
| US-6905724-B1 | Derivatization of support surfaces | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2005-06-14 | — | — | US | claimed |
| US-20050059068-A1 | Compositions and methods using dendrimer-treated microassays | STRATAGENE CALIFORNIA | 2005-03-17 | — | — | US | claimed |
| WO-2004074345-A2 | CARBONATE ESTERS OF POLYETHYLENE GLYCOL ACTIVATED BY MEANS OF OXALATE ESTERS | PHARMACIA CORPORATION (US) | 2004-09-02 | — | — | WO | claimed |
| EP-1131281-A2 | DERIVATISATION OF SUPPORT SURFACES | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2001-09-12 | — | — | EP | claimed |
| WO-2000029373-A2 | DERIVATISATION OF SUPPORT SURFACES | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2000-05-25 | — | — | WO | claimed |
| US-5446134-A | Reacting bis(fluorosulfonyl)methane salt with cyanogen halide or pseudohalide | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1995-08-29 | — | — | US | claimed |
| JP-1283550-A | — | — | None | — | — | JP | disclosed |
| US-20250367188-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | ARDELYX, INC. (US) | 2025-12-04 | — | — | US | disclosed |
| EP-0210545-A2 | Phosphorous containing enzyme inhibitors | MERCK & CO. INC. (US) | 1987-02-04 | — | — | EP | disclosed |
| EP-0209897-A2 | Peptide enzyme inhibitors | MERCK & CO. INC. (US) | 1987-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200388880-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS | SOST, CA1, DUOX2 | MGLL 4206/4885PARL 3605/4885KMT2A 1999/4885 |
| US-20100022415-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | SLC43A1, PAICS, PIGO | MGLL 4194/4885PARL 4777/4885KMT2A 4205/4885 |
| US-20250367188-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | SLC10A1, SLC10A2, FABP3 | MGLL 1217/4885PARL 4076/4885KMT2A 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.